title: A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation.
abstract: BACKGROUND
  Despite decreases in overall mortality following bone marrow transplantation (BMT), a number of complications such as neurotoxicity have been described and often associated with immunosuppressive agents. The syndrome of reversible posterior leukoencephalopathy has been described in patients receiving cyclosporin and FK-506. We report here a subset of children who developed a syndrome of previously undescribed irreversible leukoencephalopathy following allogeneic BMT.
  
  
  METHODS
  Between 1996 and 2002, 138 pediatric patients received an allogeneic BMT at Lucile Salter Packard Children's Hospital at Stanford. Six cases of irreversible leukoencephalopathy were observed. Cases were defined as children who exhibited progressive and continued, severe neurologic deterioration lasting greater than 2 weeks and consistent with non-localizing, central nervous system abnormalities. Medical records and magnetic resonance images (MRIs) were reviewed.
  
  
  RESULTS
  Median age of the affected patients at BMT was 7.8 years. All six received cyclosporine, and [corrected] one had elevated drug levels. Encephalopathy occurred at a median of 53 days (range 14-77) following BMT. Symptoms at onset of leukoenceophalopathy included confusion and altered mental status, sluggish pupillary responses, abnormal movements, and seizures. Two patients died during their neurologic decline. Four patients remain alive with persistent encephalopathy. MRI showed abnormalities in all patients including periventricular or subcortical white matter involvement in all, and basal ganglia lesions in three.
  
  
  CONCLUSIONS
  We report a syndrome of irreversible neurologic deficits and cerebral white matter abnormalities following allogeneic BMT, yet not associated with elevated cyclosporin levels. A precise mechanism for this syndrome is lacking and warrants further consideration.
authors.affiliation: School of Medicine, Stanford University, Palo Alto, California 94305, USA.
authors.forename: A Yuriko
authors.initials: AY
authors.lastname: Minn
authors.forename: Paul G
authors.initials: PG
authors.lastname: Fisher
authors.forename: Patrick D
authors.initials: PD
authors.lastname: Barnes
authors.forename: Gary V
authors.initials: GV
authors.lastname: Dahl
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D001927:Brain Diseases / Q000209:etiology*; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D013577:Syndrome; D014184:Transplantation, Homologous
chemical_list: D016572:Cyclosporine